Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
ViewAttendees 1

Preconference

Cell & Gene Therapies

Sunday, November 10, 2024
9:00 AM – 10:15 AM MST
Location: Sonoran Sky Ballroom 4

Disclosure(s):
Mark Lovern, PhD: No financial relationships to disclose
Jared Weddell, PhD: No financial relationships to disclose
Hardik Mody, PhD: No financial relationships to disclose
Ahmed Abdelhady Abozeid, PhD: Intellia Therapeutics: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Presentations:

  • 9:00 AM – 9:25 AM MST
    Hitting the target (dose) in one shot: MIDD for cell and gene therapies

    Speaker: Jared Weddell, PhD – Astellas

  • 9:25 AM – 9:50 AM MST
    Quantitative Pharmacology Considerations in the Development of Cell Therapies - Opportunities & Challenges

    Speaker: Hardik Mody, PhD (he/him/his) – Genentech

  • 9:50 AM – 10:15 AM MST
    Quantitative Pharmacology Approach to Inform the Bench-to-Bed Translation of CRSPR-Based in-vivo Gene Editing Therapy across Multiple Development Phases

    Speaker: Ahmed Abdelhady Abozeid, PhD (he/him/his) – Intellia